GlassScriptPhysician profile
Donald Ray Siddoway
NPI 1235392093
$7,568.15
in general payments reported to CMS, 2019-2025
15 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $359 · 2021: $1,678 · 2022: $1,719 · 2023: $536 · 2024: $2,035 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984 · Travel and Lodging: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.39 |
| Travel and Lodging | $966.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,100.13 | 2019-2025 | Aveir |
| Medtronic, INC. | $703.14 | 2021-2024 | Arctic Front Advance, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $654.69 | 2020-2024 | Carto 3, Qdot Micro Catheter |
| Boston Scientific Corporation | $617.38 | 2019-2025 | Watchman Access System, General - Ep, Watchman Flx |
| Medical Device Business Services, INC. | $407.29 | 2020-2024 | Carto 3 |
| Medtronic Vascular, INC. | $395.56 | 2019 | |
| Atricure, INC. | $218.86 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Cardiva Medical, INC. | $184.95 | 2024 | Savvywire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $115.13 | 2019 | |
| Philips North America LLC | $69.51 | 2022-2025 | Extended Holter |
| Cvrx, INC. | $29.97 | 2022 | |
| Biotronik INC. | $21.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.14 | 2024 | Farxiga |
| Kiniksa Pharmaceuticals, LTD. | $17.47 | 2021 | |
| Alnylam Pharmaceuticals INC. | $13.14 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Siddoway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.